First and second generations of COX-2 selective inhibitors

被引：1
|
作者：
de Leval, X
Julémont, F
Benoit, V
Frederich, M
Pirotte, B
Dogné, JM
机构：
[1] Univ Liege, Nat & Synth Drugs Res Ctr, Dept Med Chem, Med Chem Lab, B-4000 Liege, Belgium
[2] Univ Liege, Cellular & Moll Therapeut Ctr, B-4000 Liege, Belgium
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2004年 / 4卷 / 06期
关键词：
COX-2; inhibitors; selectivity; pre-clinical data;
D O I：
暂无
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The identification and characterization of the inducible form of cyclooxygenases (COX-2) stimulated the investigations to develop efficient, non-steroidal anti-inflammatory drugs (NSAIDs) with reduced side effects (essentially gastro-intestinal toxicity) compared to classical NSAIDs. This review focuses on the chemical and pharmacological properties (pre-clinical data) of marketed COX-2 inhibitors.
引用
收藏
页码：597 / 601
页数：5
相关论文
共 50 条
  • [11] New selective COX-2 inhibitors
    Kam, PCA
    Power, I
    PAIN REVIEWS, 2000, 7 (01): : 3 - 13
  • [12] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Luo, C
    He, ML
    Bohlin, L
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (08) : 926 - 933
  • [13] Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial
    Cheng Luo
    Ming-liang He
    Lars Bohlin
    Acta Pharmacologica Sinica, 2005, 26 : 926 - 933
  • [14] Potent, selective, and orally active second generation COX-2 inhibitors.
    Roy, PJ
    Brideau, C
    Chan, C
    Charleson, S
    Cromlish, W
    Ethier, D
    Evans, J
    Ford-Hutchinson, A
    Greig, G
    Gresser, M
    Grimm, E
    Guay, J
    Kargman, S
    Leblanc, Y
    Li, CS
    O'Neill, G
    Riendeau, D
    Rodger, I
    Wang, Z
    Wong, E
    Xu, L
    Young, RN
    Zamboni, R
    Prasit, P
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U861 - U861
  • [15] COX-2: Selective inhibitors in clinical trials
    Botting, J
    DRUG NEWS & PERSPECTIVES, 1996, 9 (02) : 123 - 128
  • [16] Selective COX-2 inhibitors: Are they safe for the stomach?
    Yeomans, ND
    Cook, GA
    Giraud, AS
    GASTROENTEROLOGY, 1998, 115 (01) : 227 - 229
  • [17] Selective COX-2 Inhibitors Suppress Prostacyclin
    Skarke, Carsten
    FitzGerald, Garret A.
    CLINICAL THERAPEUTICS, 2014, 36 (12) : 2121 - 2122
  • [18] Selective COX-2 inhibitors: A promise unfulfilled?
    Henry, David
    McGettigan, Patricia
    GASTROENTEROLOGY, 2007, 132 (02) : 790 - 794
  • [19] SYNTHESIS AND PHARMACOLOGY OF SELECTIVE COX-2 INHIBITORS
    ISAKSON, PC
    MEDICINAL CHEMISTRY RESEARCH, 1995, 5 (05) : 344 - 350
  • [20] Decisions loom on selective COX-2 inhibitors
    Miller, JL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (02) : 106 - 107
12345